Expert Panel
Cross-source consensus on Expert Panel from 1 sources and 5 claims.
1 sources · 5 claims
Where it comes from
Other
Other
Other
Highlighted claims
- Twelve of twenty-four invited researchers and clinicians consented to participate in the expert panel. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The panel included experts from the United States, Switzerland, and the United Kingdom. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- Half of the panel had expertise in MDMA-assisted psychotherapy safety and efficacy, and half had expertise in MDMA neuropsychopharmacology. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- Eligibility required senior or first authorship on an empirical MDMA-assisted psychotherapy study or more than five publications on acute MDMA effects in humans. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The target sample size was at least 5 to 10 panellists, matching content validation requirements. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study